SCHEMBL844900

SCHEMBL844900

COCCOCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)COCCOC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
HTT P42858 1/20 0.46
NAMPT P43490 1/20 0.44
PABPC1 P11940 1/20 0.44
TSHR P16473 1/20 0.44
EP300 Q09472 2/20 0.43
CREBBP Q92793 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
KCNH2 Q12809 1/20 0.43
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845533 0.95 CYP2C9 (0.46) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL845206 0.90 CYP2C9 (0.52) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL845251 0.82 PABPC1 (0.50) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL10119687 0.81 CYP2C9 (0.44) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL845258 0.81 MAPK1 (0.60) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL844899 0.80 NPC1 (0.52) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL845228 0.80 HCRTR1 (0.49) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL844882 0.80 PABPC1 (0.59) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL2195785 0.80 CYP2C9 (0.41) CYP2C9CYP2C19NPC1ALDH1A1MAPK1
SCHEMBL844902 0.79 ALDH1A1 (0.47) CYP2C9CYP2C19NPC1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed